Pharmasafe India conference to take up latest sector developments in drug anti-counterfeiting this month by

Second edition draws strong industry support for the second edition 

Mumbai, September 22, 2016: Following the success of the launch edition of Pharmasafe India last year, Messe Frankfurt Trade Fairs India Pvt Ltd continues its commitment to fighting the menace of counterfeit and spurious drugs and will draw attention to the latest developments in the field at the much-awaited second edition this month. The 2-day conference will take place from 22 – 23 September, 2016 at Holiday Inn, Mumbai.

Higher level representation from various government and regulatory stake holders together with the Pharma sector players at the 2-day conference is expected to transform the discussion-points into action-points for the sector. Following a special keynote address on Streamlining Anti-Counterfeiting Regulations in 2016, high-profile speakers including Dr. Shailesh Ayyangar, Managing Director, India & Vice President, South Asia, Sanofi & President, Organization of Pharmaceutical Producers of India; Dr. Rao V. S. V. Vadlamudi, President, Indian Pharmaceutical Association; Mr. Samson Chiu, Director, Asia Pacific Region, Pharmaceutical Security Institute; Mr. Edmond d’Arvieu, Vice President – Corporate Security, Sanofi, Mr. Bejon Misra, Founder, Partnership for Safe Medicines India & Mr. Prashant Tandon, Founder, 1mg will be presenting insights into the latest trends in anti-counterfeit technologies, discussions on counterfeiting in parallel trade as well as case studies on a global and domestic level.

Apart from an eminent speaker panel, the conference has also drawn support from both pharmaceutical companies and industry associations such as OPPI, IDMA, IPA, IPEC, ASPA, Sanofi and HP.The scale and scope of the event will further be enhanced by a line-up of expert speakers taking up the most pertinent and relevant topics todraw attention to the source of counterfeit medicines and effective initiatives, regulations, and policies of the USD 4.25 billion (INR 65675.5 crores) fake drugs market, in order to safeguard public health.

Messe Frankfurt has been the first trade fair organiser worldwide to launch an initiative against brand and product piracy: “Messe Frankfurt against Copying” which aims to ensure that exhibitors and visitors are fully informed and advised about the registration and assertion of intellectual property rights. In India, Messe Frankfurt has been actively involved in addressing the rising concerns on counterfeit products sold in the automotive aftermarket together with the Automotive Component Manufacturers Association of India (ACMA). Extending this initiative to the Indian pharma sector, Pharmasafe India conference aims to be the collective voice of the industry to tackle sub-standard medications in a synergised manner.

For more details on the event and delegate registrations, visit www.pharmasafeindia.com

Corporate Comm India(CCI Newswire)